| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/29/2011 | US20110236415 Virulent oncolytic herpes simplex virus strains engineered to counter the innate host response |
| 09/29/2011 | US20110236414 Bacterial Polysaccharide-Polypeptide Conjugate Compositions |
| 09/29/2011 | US20110236412 Method for Preserving Polypeptides Using a Sugar and Polyethyleneimine |
| 09/29/2011 | US20110236411 MHC Multimers in Tuberculosis Diagnostics, Vaccine and Therapeutics |
| 09/29/2011 | US20110236410 Klebsiella antigens |
| 09/29/2011 | US20110236409 Overlapping peptides from variable antigens, t cell populations and uses thereof |
| 09/29/2011 | US20110236408 Respiratory synctial virus (rsv) sequences for protein expression and vaccines |
| 09/29/2011 | US20110236407 Vaccine for runting-stunting syndrome |
| 09/29/2011 | US20110236406 Immunogenic compositions comprising hmgb1 polypeptides |
| 09/29/2011 | US20110236405 Coagulation factor modulation for controlling transplant organ size |
| 09/29/2011 | US20110236404 Methods for Protein Expression in Mammalian Cells in Serum-Free Medium |
| 09/29/2011 | US20110236403 Targeting pax2 for the induction of defb1-mediated tumor immunity and cancer therapy |
| 09/29/2011 | US20110236402 Enhancement of light activated therapy by immune augmentation using anti-ctla-4 antibody |
| 09/29/2011 | US20110236401 Compositions and methods for modulating lymphocyte activity |
| 09/29/2011 | US20110236400 Tetrahydropyranochromene gamma secretase inhibitors |
| 09/29/2011 | US20110236399 Compositions and methods for prophylactic and therapeutic treatment of infection |
| 09/29/2011 | US20110236398 Antibody Formulation |
| 09/29/2011 | US20110236397 Limited proteolysis of cd2ap and progression of renal disease |
| 09/29/2011 | US20110236396 Methods and compositions for diagnosing and treating a colorectal adenocarcinoma |
| 09/29/2011 | US20110236395 Treatment of fibrotic eye disorders using an mmp2 inhibitor |
| 09/29/2011 | US20110236394 Methods for the regulation of the prostaglandin f synthase (pgfs) activity of akr1b1 and uses thereof |
| 09/29/2011 | US20110236393 Monoclonal antibody production in b cells and uses therof |
| 09/29/2011 | US20110236392 Composition and method for treatment of preterm labor |
| 09/29/2011 | US20110236391 Method for obtaining an excipient-free antibody solution |
| 09/29/2011 | US20110236390 IL-17A Antagonists |
| 09/29/2011 | US20110236389 Human Angiostatin Interacting and Tumor Metastasis Involving Protein Variants and Uses Thereof |
| 09/29/2011 | US20110236388 Bispecific, bivalent anti-vegf/anti-ang-2 antibodies |
| 09/29/2011 | US20110236387 Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof |
| 09/29/2011 | US20110236386 Novel method for prediction of cardiovascular disease risk in type 2 diabetes |
| 09/29/2011 | US20110236385 Blocking mesothelin peptide fragments |
| 09/29/2011 | US20110236384 Direct drug delivery system based on thermally responsive biopolymers |
| 09/29/2011 | US20110236383 Protein Formulation |
| 09/29/2011 | US20110236382 Immunosuppressive combination and its use in the treatment or prophylaxis of insulin-producing cell graft rejection |
| 09/29/2011 | US20110236381 Inhibition of inter-alpha trypsin inhibitor for the treatment of airway disease |
| 09/29/2011 | US20110236380 Ligands that bind il-13 |
| 09/29/2011 | US20110236379 Pharmaceutical combinations comprising a pyrido [4,3-d] pyrimidine derived hsp90-inhibitor and a her2 inhibitor |
| 09/29/2011 | US20110236378 Non-human mammals for the production of chimeric antibodies |
| 09/29/2011 | US20110236377 Hepatocyte Growth Factor (HGF) Binding Proteins |
| 09/29/2011 | US20110236376 Non-neutralizing immunity to influenza to prevent secondary bacterial pneumonia |
| 09/29/2011 | US20110236375 Antibody variants with enhanced complement activity |
| 09/29/2011 | US20110236374 Genetically recombinant antibody composition capable of binding specifically to ganglioside gm2 |
| 09/29/2011 | US20110236373 Method of detecting antibodies and antibody-hiv virion complexes |
| 09/29/2011 | US20110236372 Display Library for Antibody Selection |
| 09/29/2011 | US20110236371 Compositions And Methods For The Treatment Of Neurologic And Psychiatric Conditions |
| 09/29/2011 | US20110236370 Genetic Alterations on Chromosomes 21q, 6q and 15q and Methods of Use Thereof for the Diagnosis and Treatment of Type I Diabetes |
| 09/29/2011 | US20110236349 Use of Epidermal Growth Factor Inhibitors in the Treatment of Viral Infection |
| 09/29/2011 | US20110236347 Monoclonal Anti-Claudin 1 Antibodies for the Inhibition of Hepatitis C Virus Infection |
| 09/29/2011 | US20110236345 Composition and methods for eliciting an immune response |
| 09/29/2011 | US20110236344 Synthetic mimics of mammalian cell surface receptors: method and compositions |
| 09/29/2011 | US20110236314 Method of detection and diagnosis of oral and nasopharyngeal cancers |
| 09/29/2011 | US20110236309 Antagonists of ligands and uses thereof |
| 09/29/2011 | US20110236306 Compositions and methods for the removal of biofilms |
| 09/29/2011 | US20110236305 Methods for protecting and regenerating bone marrow using cxcr3 agonists and antagonists |
| 09/29/2011 | US20110236304 Structural variants of antibodies for improved therapeutic characteristics |
| 09/29/2011 | CA2831262A1 N-cadherin: target for cancer diagnosis and therapy |
| 09/29/2011 | CA2794558A1 Hiv vaccine |
| 09/29/2011 | CA2794483A1 Vista regulatory t cell mediator protein, vista binding agents and use thereof |
| 09/29/2011 | CA2794359A1 Infectious hepatitis c virus-high producing hcv variants and use thereof |
| 09/29/2011 | CA2793985A1 Proangiogenic compositions, method for preparing same, and uses thereof |
| 09/29/2011 | CA2793959A1 Cmv glycoproteins and recombinant vectors |
| 09/29/2011 | CA2793753A1 Antibodies to muc16 and methods of use thereof |
| 09/29/2011 | CA2793750A1 Method and compositions to induce apoptosis of tumoral cells expressing shh |
| 09/29/2011 | CA2793214A1 Papillomavirus virus-like particle or capsomere formulation and its use as microbicide |
| 09/29/2011 | CA2792125A1 Compositions and methods useful for stabilizing protein-containing formulations |
| 09/29/2011 | CA2791991A1 Anti-lrp6 antibodies |
| 09/29/2011 | CA2789074A1 Bispecific antibodies |
| 09/28/2011 | EP2369345A1 Glycoconjugates and their use as potential vaccines against infection by shigella flexneri |
| 09/28/2011 | EP2369014A1 Compositions and methods for characterizing, regulating, diagnosing and treating cancer |
| 09/28/2011 | EP2368998A1 RSV F protein and use of same |
| 09/28/2011 | EP2368986A1 Promoter for introducing gene into lymphocyte or blood cell and application thereof |
| 09/28/2011 | EP2368985A2 Compositions and methods for generating an immune response |
| 09/28/2011 | EP2368914A1 Anti-5T4 antibodies and uses thereof |
| 09/28/2011 | EP2368910A1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 09/28/2011 | EP2368907A2 Anti-Abeta antibodies and their use |
| 09/28/2011 | EP2368899A1 Avian influenza vaccine |
| 09/28/2011 | EP2368578A1 Identification and engineering of antibodies with variant Fc regions and methods of using same |
| 09/28/2011 | EP2368577A2 Methods for treating interleukin-6 related diseases |
| 09/28/2011 | EP2368576A2 Functionally reconstituted viral membranes containing adjuvant |
| 09/28/2011 | EP2368575A2 Dry formulation for transcutaneous immunization |
| 09/28/2011 | EP2368574A1 Allergen peptide fragments and use thereof |
| 09/28/2011 | EP2368573A2 Influenza vaccines including combinations of particulate adjuvants and immunopotentiators |
| 09/28/2011 | EP2368572A2 Adjuvanted vaccines with non-virion antigens prepared from influenza viruses grown in cell culture |
| 09/28/2011 | EP2368571A1 Recombinant attenuated clostridium organisms and vaccine |
| 09/28/2011 | EP2368570A2 Compositions and methods related to staphylococcal bacterium proteins |
| 09/28/2011 | EP2368569A2 Compositions and methods related to staphylococcal bacterium proteins |
| 09/28/2011 | EP2368568A1 Compositions and methods for immunodominant antigens |
| 09/28/2011 | EP2368564A1 Pharmaceutical composition for acute phase protein targeted treatment of acute and chronic dysregulated inflammatory diseases or conditions |
| 09/28/2011 | EP2368431A1 Immunostimulatory G,U-containing oligoribonucleotides |
| 09/28/2011 | EP2367945A1 Single recombination system and methods of use |
| 09/28/2011 | EP2367944A1 Promoters for recombinant viral expression |
| 09/28/2011 | EP2367849A1 Method for the treatment of neurodegenerative diseases |
| 09/28/2011 | EP2367844A2 Rsv f vlps and methods of manufacture and use thereof |
| 09/28/2011 | EP2367570A2 Antibodies to il-6 and use thereof |
| 09/28/2011 | EP2367569A1 Ljungan virus |
| 09/28/2011 | EP2367568A2 Meningococcal vaccines including hemoglobin receptor |
| 09/28/2011 | EP2367567A1 Antigen-presenting scaffolds |
| 09/28/2011 | EP2367566A2 Recombinant avian influenza vaccine and uses thereof |
| 09/28/2011 | EP2367565A1 Methods for the treatment and the prognostic assessment of malignant pleural mesothelioma. |
| 09/28/2011 | EP2367553A1 Combination therapy to enhace nk cell mediated cytotoxicty |
| 09/28/2011 | EP2367550A1 Il-3 inhibitors in use for treatment of rheumatoid arthritis in an early stage |